Performance of a pediatric adaptation of the RITE2 and APE2 scores in children with autoimmune epilepsy: P-RITE2 and P-APE2 scores

Panda, Prateek Kumar; Ramachandran, Aparna; Suthar, Renu; Tomar, Apurva; Elwadhi, Aman; Panda, Prateek Kumar; Bhat, Nowneet Kumar

doi:10.1016/j.seizure.2022.10.005

Seizure: European Journal of Epilepsy

2022

DOI: 10.1016/j.seizure.2022.10.005

|View full text |Cite

Performance of a pediatric adaptation of the RITE2 and APE2 scores in children with autoimmune epilepsy: P-RITE2 and P-APE2 scores

Prateek Kumar Panda

Aparna Ramachandran²,

Renu Suthar

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Paediatric antibody prevalence in seizure score to predict autoimmune aetiology in seizure disorders

Mori,

Matsuda,

Nishida

et al. 2024

Develop Med Child Neuro

View full text Add to dashboard Cite

AimTo modify the antibody prevalence in epilepsy (APE) score of children with suspected autoimmune central nervous system disease with seizures.MethodsWe retrospectively analysed the cerebrospinal fluid of 157 children (aged 0–18 years) with suspected autoimmune central nervous system disease for antineuronal antibodies in our laboratory from 2016 to 2023. Participants were randomly divided into the development cohort (n = 79, 35 females; median 7 years, SD 4 years 7 months, range 4–11 years) and validation cohort (n = 78, 28 females; median 7 years, SD 4 years 5 months, range 4–12 years). A paediatric antibody prevalence in seizure (PAPS) score was created for one cohort and evaluated in the other. Seven variables were selected through univariate and multivariate analysis to create a PAPS score.ResultsOne hundred and fifty‐seven children who fulfilled the inclusion criteria were enrolled; 49 tested positive for antineuronal antibodies. The sensitivity and specificity of an APE score of 4 and greater were 92% and 22.2% respectively; the sensitivity and specificity of a PAPS score of 2.5 and greater were 83.3% and 77.8% respectively. The area under the curve was 0.832 (95% confidence interval = 0.743–0.921), which was significantly better than that for the APE score (p < 0.001).InterpretationThe APE score had high sensitivity but low specificity in children. The PAPS score may be useful for determining the need for antineuronal antibody testing.

show abstract

Paediatric antibody prevalence in seizure score to predict autoimmune aetiology in seizure disorders

Mori,

Matsuda,

Nishida

et al. 2024

Develop Med Child Neuro

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Performance of a pediatric adaptation of the RITE2 and APE2 scores in children with autoimmune epilepsy: P-RITE2 and P-APE2 scores

Cited by 1 publication

References 23 publications

Paediatric antibody prevalence in seizure score to predict autoimmune aetiology in seizure disorders

Paediatric antibody prevalence in seizure score to predict autoimmune aetiology in seizure disorders

Contact Info

Product

Resources

About